UPDATE – SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) will release its second quarter 2021 financial results on September 9, 2021, before market open. The management will host a conference call at 8:30 a.m. ET to discuss these results, alongside business developments and future outlook. The company focuses on data-driven medicine and operates the SOPHiA DDM™ Platform, utilized by over 780 institutions globally. A live webcast of the call will be accessible in the 'Investors' section of their website, with an archived replay available post-event.

Positive

• SOPHiA DDM™ Platform is used by over 780 institutions globally.

Negative

• None.

BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open on Thursday, September 9, 2021. The company’s management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time to discuss its results, business developments, and outlook.

Live audio of the webcast will be available on the “Investors” section of the company website at: ir.sophiagenetics.com. An archived replay will be available on the company’s website following the event.

About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.

Media Contact:
sophiagenetics@consortpartners.com

Investor Contact:
ir@sophiagenetics.com

Carrie Mendivil
carrie@gilmartinir.com

FAQ

When will SOPHiA GENETICS report its Q2 2021 financial results?

SOPHiA GENETICS will report its Q2 2021 financial results on September 9, 2021, before market open.

What time will the SOPHiA GENETICS conference call take place?

The conference call will begin at 8:30 a.m. Eastern Time on September 9, 2021.

Where can I listen to the SOPHiA GENETICS earnings call?

The earnings call will be available via webcast on the 'Investors' section of the SOPHiA GENETICS website.

What platform does SOPHiA GENETICS use for data-driven medicine?

SOPHiA GENETICS uses the SOPHiA DDM™ Platform for data-driven medicine.